首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

SEMINARS IN CANCER BIOLOGY
ISSN：1044-579X

SEMINARS IN CANCER BIOLOGY

SEMIN CANCER BIOL
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学1区
年发文量：42
影响因子：15.7
JCR分区：Q1

基本信息

《癌症生物学研讨会》是一份评论期刊，致力于让科学家们了解分子肿瘤学领域的发展。每一期都是主题性的，致力于癌症生物学家感兴趣的重要主题，从细胞转化和癌症的潜在遗传和分子原因到潜在治疗的分子基础。每期由一名或多名客座编辑编辑编辑，即该领域国际公认的专家，并包含大约8至12篇关于该主题领域不同方面的权威特邀评论。每期的目的是提供一个协调，可读，生动的审查选定的领域，迅速出版，以确保货币。
1044-579XSCIE/Scopus收录
15.7
点击查看最新影响趋势>
19.2
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
ONCOLOGY 肿瘤学
1区
是
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ONCOLOGY
SCIE
Q1
18/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ONCOLOGY
SCIE
Q1
15/328
134
42
点击查看年发文量趋势图>
9%0较慢,6-12周-医学-肿瘤学
0.6%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
95.24%23.81%-
CiteScore：35.00
SJR：4.016
SNIP：2.700
学科类别分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Cancer Research
Q1
8 / 233

期刊高被引文献

Matrix Metalloproteinases: A challenging paradigm of cancer management.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2017.11.008
CRISPR/Cas9 for cancer research and therapy.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2018.04.001
The role of SOX family members in solid tumours and metastasis.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.03.004
Akt in cancer: Mediator and more.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.06.002
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.002
SOX2 in development and cancer biology.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.007
Immune checkpoints in the tumor microenvironment.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.06.021
The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.10.013
The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.12.007
At a Glance: A History of Autophagy and Cancer.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.11.005
Risk of colorectal cancer in inflammatory bowel diseases.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.05.001
Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.05.003
Metabolic flexibility in melanoma: a potential therapeutic target.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.07.016
Role of cell surface proteoglycans in cancer immunotherapy.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.07.012
Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2018.04.002
SOX4: The Unappreciated Oncogene.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.027
MicroRNA heterogeneity in melanoma progression.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.05.021
Role of ATP-binding cassette transporters in cancer initiation and progression.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.006
Oncogenic signaling pathways associated with immune evasion and the resistance to immune checkpoint inhibitors in cancer.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.11.011
Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2017.11.002
Monitoring autophagy in cancer: from bench to bedside.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.05.016
Glyco-Nanoparticles: New drug delivery systems in cancer therapy.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.12.004
SOX4: Epigenetic Regulation and Role in Tumorigenesis.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.06.022
Ras and exosome signaling.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.02.004
Repurposing Antipsychotics of the Diphenylbutylpiperidine Class for Cancer Therapy.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.10.007
Pro-survival Autophagy: An Emerging Candidate of Tumor Progression through Maintaining Hallmarks of Cancer.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.020
Autophagy proteins influence endocytosis for MHC restricted antigen presentation.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.03.005
Recent insights into apoptosis and toxic autophagy: the roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.07.013
Implications of nanotechnology for the treatment of cancer: Recent advances.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.028
Tumor Biology and Multidisciplinary Strategies of Oligometastasis in Gastrointestinal Cancers.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.026
Exploiting epigenetic vulnerabilities in solid tumors: novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.09.018
Exploring the roles of MACIT and Multiplexin collagens in stem cells and cancer.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.033
NANOMEDICINE IN TREATMENT OF BREAST CANCER - A CHALLENGE TO CONVENTIONAL THERAPY.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.12.016
Role of AHR in the control of GBM-associated myeloid cells.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.05.014
Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.09.025
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.06.011
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.08.029
The Molecular Biology of Pancreatic Neuroendocrine Neoplasms: Challenges and Translational Opportunities.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.09.024
Role of bioactive lipofishins in prevention of inflammation and colon cancer.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2017.11.012
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.12.001
Exploring MYC relevance to cancer biology from the perspective of cell competition.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.05.009
Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges
来源期刊：Seminars in Cancer BiologyDOI：10.1016/J.SEMCANCER.2019.08.030
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.10.015
New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2018.02.008
CD95/Fas and metastatic disease: What does not kill you makes you stronger.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.06.004
Transcriptional versus metabolic control of cell fitness during cell competition
来源期刊：Seminars in Cancer BiologyDOI：10.1016/j.semcancer.2019.05.010
Cell Competition in Tumor Evolution and Heterogeneity: Merging Past and Present.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.07.008
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.10.008
What patents tell us about drug repurposing for cancer: A landscape analysis.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.09.010
Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
来源期刊：Seminars in cancer biologyDOI：10.1016/j.semcancer.2019.12.009

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

Acta Biomaterialia封面

Acta Biomaterialia

学科领域：医学
影响因子：9.6
中科院分区： 1区
ACTA PHARMACOLOGICA SINICA封面

ACTA PHARMACOLOGICA SINICA

学科领域：医学
影响因子：8.4
中科院分区： 1区
ADVANCED DRUG DELIVERY REVIEWS封面

ADVANCED DRUG DELIVERY REVIEWS

学科领域：医学
影响因子：17.6
中科院分区： 1区
AGEING RESEARCH REVIEWS封面

AGEING RESEARCH REVIEWS

学科领域：医学
影响因子：12.4
中科院分区： 1区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学1区
ONCOLOGY 肿瘤学
1区
是
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
是
是
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
ONCOLOGY 肿瘤学
2区
是
是